Search Results

Displaying Results 2301-2325 of 2518 "'ML'"

Oct 08, 2025, 09:00 ET Cisco Sets Benchmark with Industry's Most Scalable, Efficient 51.2T Routing Systems for Distributed AI Workloads

of Silicon One, and the common ASIC architecture has made it easier for us to expand from our initial use cases to multiple roles in DC, WAN, and AI/ML environments." - Dave Maltz, Technical Fellow and Corporate Vice President, Azure Networking, Microsoft "As Alibaba continues

More news about: Cisco Systems, Inc.


Oct 08, 2025, 08:45 ET SQ Innovation AG Announces the Appointment of Two New Board Members and Successful Closing of Series B Financing to Support the U.S. Launch of Lasix® ONYU

financing, led by Mr. van der Poel, providing the capital necessary for the U.S. commercial launch of Lasix® ONYU (furosemide injection) 80 mg/2.67 mL for subcutaneous use which was approved by the FDA on October 7, 2025. For more information, please visit:

More news about: SQ Innovation


Oct 08, 2025, 08:35 ET PASSUR Aerospace Appoints Ilhan Ince as CEO

improve decision making, collaboration, efficiency, reliability, and the customer experience," said Ince. "At PASSUR, we're leveraging cutting-edge AI/ML, rigorous data fusion, and deep human expertise to help our customers make smarter, faster decisions.  I'm proud that PASSUR is a trusted partner to

More news about: PASSUR Aerospace, Inc.


Oct 08, 2025, 08:30 ET SQ Innovation Announces FDA Approval of Lasix® ONYU for Treatment of Edema in Heart Failure

pharmaceutical component of Lasix ONYU is a novel, high-concentration formulation of the diuretic furosemide, at 30 mg/mL. It comes in a pre-filled glass cartridge containing 80 mg of furosemide in 2.67 mL.  The Lasix ONYU Infusor consists of two main parts: the Reusable Unit and the Disposable Unit. The Reusable

More news about: SQ Innovation


Oct 08, 2025, 08:00 ET WE'VE CHANGED THE GAME AGAIN. MEET THE ONE YOU'VE BEEN WAITING FOR…

Wonderskin Hyper-Bond™ Serum Foundation 30ml $42 Vegan, alcohol and talc-free, non-comedogenic, fragrance-free, cruelty-free, and PFAS-free.

More news about: Wonderskin


Oct 08, 2025, 07:05 ET Telecom Engineering Expert Dr. Radostin Pachamanov Joins Quandary Peak Research

telecommunications systems, Internet protocols, network security, ephemeral messaging platforms, AI/ML applications such as automotive collision detection, and

More news about: Quandary Peak Research


Oct 08, 2025, 07:00 ET TopGum Expands into Sports Nutrition with Potent Electrolyte and Creatine Gummies

formulated these gummies to carry the highest dose-per-gram of electrolytes available on the market. Four gummies provide the same electrolyte dose as a 330ml bottle of a hydration sports beverage while still striking the perfect balance between salt and sweet notes for a fun and enjoyable flavor experience."

More news about: TopGum Industries, Inc.


Oct 07, 2025, 12:59 ET KENTRO APPOINTS ASHLEY CULBERTSON AS SENIOR DIRECTOR OF GROWTH

evolving mission environments. We enable more informed, more confident decisions with innovative data services and cutting-edge capabilities like AI/ML to create a clearer picture of what's next, now. In a landscape where mission alignment determines mission success, we're creating the core of a more

More news about: Kentro


Oct 07, 2025, 11:41 ET HENNESSY AND LEBRON JAMES LAUNCH A NEW COLLECTOR'S V.S.O.P LIMITED EDITION

Signature Serve 40 ml Hennessy V.S.O.P 15 ml Orange Liqueur 20 ml Fresh Lemon Juice 10 ml simple syrup 1 Garnish: Lemon twist

More news about: Hennessy


Oct 07, 2025, 11:36 ET Crunch Lab Raises $5M to Build the Intelligence Layer for Decentralized AI

Crunch Lab stands at the forefront of AI research, uniting Nobel laureates, best in class data scientists, and leading ML experts. Its work explores the frontier of collective intelligence, enabling enterprises to harness real-time predictive capabilities without compromising

More news about: Crunch Lab


Oct 07, 2025, 11:11 ET IotaComm® Expands Leadership Team, Renews Board Terms, and Strengthens Focus on Growth and Impact

Dr. Wael Guibene is a seasoned product and technology executive with over 15 years of leadership across wireless, IoT, and AI/ML platforms. He has built category-defining, edge-to-cloud products that translate deep radio systems expertise— LoRaWAN®, Thread/Matter, Wi-Fi,

More news about: IotaComm


Oct 07, 2025, 09:00 ET Xcelerate Solutions Acquires clearAvenue

clearAvenue. Based in Columbia, Maryland, clearAvenue provides software development & maintenance, business intelligence and analysis, AI/ML, big data analytics and  infrastructure, and cloud services support across federal agencies. The combined company will go to market as Xcelerate Solutions,

More news about: Xcelerate Solutions


Oct 07, 2025, 09:00 ET Ryff Launches Scene Intelligence™: New AI Framework Connects On-Screen Moments to Real-World Actions

Based in Los Angeles, Ryff specializes in In-Scene Advertising. Its proprietary GPU-based visual computing, AI, and ML platform, Spheera™, ingests, analyzes, and delivers brand and product integrations at scale across sport, film, TV, and social media. Targeting the $190

More news about: Ryff


Oct 07, 2025, 08:43 ET Seceon Announces CGuard 2.0: A Revolutionary Leap in Cloud Threat Detection and Response

About Seceon Seceon powers the Open Threat Management (OTM) platform, an AI/ML-driven solution built to detect, protect, and respond in real time. Designed for enterprises and MSSPs alike, the unified architecture eliminates blind

More news about: Seceon Inc.


Oct 07, 2025, 08:05 ET TREMFYA® (guselkumab) is first and only IL-23 inhibitor to demonstrate sustained clinical and endoscopic outcomes with a fully subcutaneous regimen through 48 weeks in ulcerative colitis

Dosage Forms and Strengths: TREMFYA® is available as 100 mg/mL and 200 mg/2mL for subcutaneous injection and as a 200 mg/20 mL (10 mg/mL) single dose vial for intravenous infusion. ABOUT JOHNSON & JOHNSONAt

More news about: Johnson & Johnson


Oct 07, 2025, 08:03 ET Gurucul and Blue Mantis Partner to Provide Unparalleled, AI-Powered Detection and Enterprise-Grade Protection

Blue Mantis Protect MDR offering, unifying award winning behavioral ML analytics, cost-optimized data pipeline management, and agentic AI workflows for comprehensive and efficient threat detection and response.   

More news about: Gurucul


Oct 07, 2025, 08:00 ET AI Adoption Surges in Supply Chains as Companies Prioritize Network Intelligence

"In most network design and optimization cases, traditional AI or Machine Learning (ML) remains sufficient to run necessary analysis, but Generative AI is beginning to play a role in creating more intuitive interfaces for users to interact

More news about: ABI Research


Oct 07, 2025, 08:00 ET ikeGPS Launches AI-Powered Assistant to Increase Productivity for Analyzing Utility Pole Data

PolePilot™, a new automated assistant for utility pole data analysis. Powered by IKE's advanced AI/ML algorithms and image recognition capabilities, PolePilot is designed to accelerate common tasks involving overhead asset data. Now available within

More news about: ikeGPS Inc


Oct 07, 2025, 06:58 ET Tech Basel Miami AI Summit To Ignite Next Wave of Innovation

4A LabsCelenk leads a team dedicated to delivering cutting-edge technology solutions. Their core focus includes AI/ML development, Blockchain, deFi, Smart Contract applications, computer vision and traditional SW design & development services tailored for startups

More news about: eMerge Americas


Oct 07, 2025, 06:45 ET Lilly's Omvoh (mirikizumab-mrkz) is the first and only IL-23p19 antagonist to show four years of sustained, corticosteroid-free comprehensive patient outcomes in ulcerative colitis

elevated liver tests. Omvoh injection is available as a 300 mg/15 mL solution in a single-dose vial for intravenous infusion, and as a 100 mg/mL solution or a 200 mg/2 mL solution in a single dose prefilled pen or prefilled syringe for subcutaneous injection. Refer to the

More news about: Eli Lilly and Company


Oct 07, 2025, 06:30 ET CtrlS Datacenters Receives Frost & Sullivan's 2025 India Competitive Strategy Leadership Recognition in Data Center Services

CtrlS demonstrated excellence in both, successfully aligning its strategy with the growing demand for artificial intelligence (AI), machine learning (ML), cloud computing, and large language model (LLM) workloads. "CtrlS has demonstrated a strong competitive strategy based on aligning to the changing customer

More news about: Frost & Sullivan


Oct 07, 2025, 06:30 ET CtrlS Datacenters Receives Frost & Sullivan's 2025 India Competitive Strategy Leadership Recognition in Data Center Services

CtrlS demonstrated excellence in both, successfully aligning its strategy with the growing demand for artificial intelligence (AI), machine learning (ML), cloud computing, and large language model (LLM) workloads. "CtrlS has demonstrated a strong competitive strategy based on aligning to the changing customer

More news about: Frost & Sullivan


Oct 06, 2025, 22:28 ET BitMine Immersion (BMNR) annuncia che le partecipazioni in ETH superano 2,83 milioni di token e che le partecipazioni totali in criptovalute e contanti ammontano a 13,4 miliardi di dollari

i-in-eth-superano-2-83-milioni-di-token-e-che-le-partecipazioni-totali-in-criptovalute-e-contanti-ammontano-a-13-4-miliardi-di-dollari-302576448.html

More news about: BitMine Immersion Technologies, Inc.


Oct 06, 2025, 17:00 ET ATLANTIS PARADISE ISLAND ANNOUNCES THE RETURN OF ITS LEGENDARY PARTY LIKE A ROYAL NEW YEAR'S EVE CELEBRATION WITH HOST ARIANA MADIX, HEADLINERS TWO FRIENDS, AND A SPECIAL SURPRISE MUSICAL GUEST

endary-party-like-a-royal-new-years-eve-celebration-with-host-ariana-madix-headliners-two-friends-and-a-special-surprise-musical-guest-302576244.html SOURCE Atlantis, Paradise Island

More news about: Atlantis, Paradise Island


Oct 06, 2025, 16:30 ET Eisai and Biogen Announce U.S. Availability of LEQEMBI® IQLIK™ (lecanemab-irmb) Subcutaneous Injection Maintenance Dose for Treatment of Early Alzheimer's Disease

(lecanemab-irmb) is available: Intravenous infusion: 100 mg/mL Subcutaneous injection: 200 mg/mL Please see full

More news about: Eisai Inc.


Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.